A top-10 pharmaceutical company initiated a Phase III clinical trial to evaluate its compound’s ability to increase muscle mass and strength and improve mobility in older adults with sarcopenia.
This sponsor was hoping to expand its presence in inflammation and autoimmunity with four global, pivotal phase III protocols in patients with moderately-to-severely active rheumatoid arthritis.
This phase III global program, involving four protocols and approximately 300 sites, was critical for a sponsor striving to make its compound the leader in a potential $1B gout market.
Let Acurian do the heavy lifting for your musculoskeletal trial.
Our extensive experience with musculoskeletal trials includes osteoarthritis, low back pain, rheumatoid arthritis, fibromyalgia, gout, and knee pain. We do the heavy lifting for you, providing patient enrollment and retention that helps your trial proceed on time and on budget.
Acurian has recruited and enrolled thousands of patients for more than 60 pharmaceutical and biotech companies representing over 4,500 research sites.